News Daily News Texting Tool Failed to Up Pill Adherence in ACS Patients: TEXTMEDS Caitlin E. Cox May 10, 2022
News Daily News Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV Michael O'Riordan May 09, 2022
News Daily News The Hunt for Protein Culprits in COVID-19’s Cardiac Complications Michael O'Riordan May 06, 2022
News Daily News Risk of Repeat Stroke Underrecognized in Nonstenotic Carotid Lesions L.A. McKeown May 06, 2022
News Conference News HRS 2022 Evidence Grows for Conduction-System Pacing as an Alternative to CRT Todd Neale May 05, 2022
News Daily News Age and Fitness Biggest Predictors of Mortality in CAD Patients, AI Study Shows Michael O'Riordan May 04, 2022
News Daily News Frailty Does Not Hinder Dapagliflozin’s HFrEF Impact: DAPA-HF Analysis Caitlin E. Cox May 03, 2022
News Conference News HRS 2022 Gains in HF Drug Therapy Raise Questions About ICD Benefit in Modern Era Todd Neale May 02, 2022
News Conference News HRS 2022 Intensive BP Control May Stave Off LV Conduction Disease: SPRINT Todd Neale May 02, 2022
News Conference News HRS 2022 Registry Shows Watchman FLX Beating First-Gen Device for Early LAAO Outcomes Todd Neale May 02, 2022
News Daily News Making a Game of Digital Tools Ups Exercise in High-Risk Postpartum Women Caitlin E. Cox April 25, 2022
News Daily News Revascularization’s Benefits in HFrEF Linked to Gains in LV Function Caitlin E. Cox April 15, 2022
News Daily News MOSAIC: Home Intervention Boosts Walking Time in PAD Patients L.A. McKeown April 15, 2022
News Conference News ACC 2022 No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3 Michael O'Riordan April 13, 2022
News Conference News ACC 2022 METEORIC-HF: Omecamtiv Mecarbil Doesn’t Boost Exercise Capacity in HFrEF Todd Neale April 08, 2022
News Conference News ACC 2022 SPYRAL HTN-ON MED at 3 Years: Renal Denervation’s BP Impact Endures Todd Neale April 08, 2022
News Conference News ACC 2022 Modest Effects, Safety Concerns Plague Vupanorsen in TRANSLATE-TIMI 70 Michael O'Riordan April 07, 2022
News Conference News ACC 2022 QoL Gains Within 15 Days in Acute HF With Empagliflozin: EMPULSE Analysis L.A. McKeown April 07, 2022